Incorporation of lipolysis in monolayer permeability studies of lipid-based oral drug delivery systems

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Drug Delivery and Translational Research

• Publication date

  2018-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s13346-017-0383-6PMID 28462499
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 50years of oral lipid-based formulations: Provenance, progress and future perspectives.

  2016cited by this paper
• Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs.

  2016cited by this paper
• years of oral lipid-based formulations : Provenance , progress and future perspectives ☆

  2016influential reference
• In vivo evaluation of lipid-based formulations for oral delivery of apomorphine and its diester prodrugs.

  2016cited by this paper
• In Vitro Lipolysis Data Does Not Adequately Predict the In Vivo Performance of Lipid-Based Drug Delivery Systems Containing Fenofibrate

  2014influential reference
• Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: case studies with fenofibrate.

  2014cited by this paper
• Comparison of MDCK-MDR1 and Caco-2 cell based permeability assays for anti-malarial drug screening and drug investigations.

  2014cited by this paper
• Self-Nanoemulsifying Drug Delivery System of Nifedipine: Impact of Hydrophilic–Lipophilic Balance and Molecular Structure of Mixed Surfactants

  2014cited by this paper
• In vitro-in vivo evaluation of lipid based formulations of the CETP inhibitors CP-529,414 (torcetrapib) and CP-532,623.

  2014cited by this paper
• Pharmacokinetic aspects and in vitro–in vivo correlation potential for lipid-based formulations

  2014cited by this paper
• Permeability of rhynchophylline across human intestinal cell in vitro.

  2014cited by this paper
• Oral lipid-based drug delivery systems – an overview

  2013cited by this paper
• Development and evaluation of a novel microemulsion formulation of elacridar to improve its bioavailability.

  2013cited by this paper
• Formulation Strategies to Improve the Bioavailability of Poorly Absorbed Drugs with Special Emphasis on Self-Emulsifying Systems

  2013cited by this paper
• Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations.

  2012cited by this paper
• Brain Distribution and Bioavailability of Elacridar after Different Routes of Administration in the Mouse

  2012cited by this paper
• Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems.

  2012cited by this paper
• Absorption Enhancers: Applications and Advances

  2012cited by this paper
• A simplified protocol employing elacridar in rodents: a screening model in drug discovery to assess P-gp mediated efflux at the blood brain barrier.

  2012cited by this paper
• Drug-permeability and transporter assays in Caco-2 and MDCK cell lines.

  2011cited by this paper
• Predicting Intestinal Precipitation—A Case Example for a Basic BCS Class II Drug

  2010cited by this paper
• Development of solid lipid nanoparticles for enhanced solubility of poorly soluble drugs.

  2010cited by this paper
• Development of Microemulsion for Solubility Enhancement of Clopidogrel

  2010cited by this paper
• Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay.

  2010cited by this paper
• Formulation and characterization of an oily-based system for oral delivery of insulin.

  2009cited by this paper
• Lipid--an emerging platform for oral delivery of drugs with poor bioavailability.

  2009cited by this paper
• Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound.

  2008cited by this paper
• Effects of monoglycerides on rhodamine 123 accumulation, estradiol 17 beta-D-glucuronide bidirectional transport and MRP2 protein expression within Caco-2 cells.

  2008cited by this paper
• Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs

  2007influential reference
• When poor solubility becomes an issue: from early stage to proof of concept.

  2007cited by this paper
• Development of In Vitro Pharmacokinetic Screens Using Caco-2, Human Hepatocyte, and Caco-2/Human Hepatocyte Hybrid Systems for the Prediction of Oral Bioavailability in Humans

  2007cited by this paper
• Myosin Light Chain Kinase Inhibition: Correction of Increased Intestinal Epithelial Permeability In Vitro

  2007cited by this paper
• Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies.

  2007cited by this paper
• Enhancing mechanism of Labrasol on intestinal membrane permeability of the hydrophilic drug gentamicin sulfate.

  2006cited by this paper
• Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability.

  2006cited by this paper
• Self-Emulsifying Drug Delivery Systems: Formulation and Biopharmaceutic Evaluation of an Investigational Lipophilic Compound

  2004cited by this paper
• Comparison of in Vitro Models for the Prediction of Compound Absorption across the Human Intestinal Mucosa

  2004cited by this paper
• Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.

  2004cited by this paper
• The Madin Darby Canine Kidney (MDCK) Epithelial Cell Monolayer as a Model Cellular Transport Barrier

  2004cited by this paper
• Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.

  2004cited by this paper
• Intestinal Lymphatic Transport of Halofantrine Occurs After Oral Administration of a Unit-Dose Lipid-Based Formulation to Fasted Dogs

  2003cited by this paper
• High throughput artificial membrane permeability assay for blood-brain barrier.

  2003cited by this paper
• Microemulsion formulation for enhanced absorption of poorly soluble drugs. II. In vivo study.

  2002cited by this paper
• Evaluation of the in‐vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products

  2002cited by this paper
• A dynamic in vitro lipolysis model. II: Evaluation of the model.

  2001cited by this paper
• Fat digestion modulates gastrointestinal sensations induced by gastric distention and duodenal lipid in humans.

  2001cited by this paper
• Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment.

  2001cited by this paper
• Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis.

  2001cited by this paper
• A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium.

  2001cited by this paper
• Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs.

  2000cited by this paper
• Improved bioavailability of vitamin E with a self emulsifying formulation.

  2000cited by this paper
• Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems.

  2000cited by this paper
• MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening.

  1999influential reference
• Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine

  1998cited by this paper
• Influence of lipolysis on drug absorption from the gastro-intestinal tract

  1997cited by this paper
• Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum.

  1996cited by this paper
• Angiotensin-converting enzyme inhibitors regulate the Na(+)-K+ pump via effects on angiotensin metabolism.

  1996cited by this paper
• Lipid Microemulsions for Improving Drug Dissolution and Oral Absorption: Physical and Biopharmaceutical Aspects

  1995cited by this paper
• Improved Dose Linearity of Cyclosporine Pharmacokinetics from a Microemulsion Formulation

  1994cited by this paper
• In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.

  1993cited by this paper
• Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

  1991cited by this paper
• Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings.

  1990cited by this paper
• Temporal relationships of cholecystokinin release, pancreatobiliary secretion, and gastric emptying of a mixed meal.

  1988cited by this paper
• Physicochemical properties of bile acids and their relationship to biological properties: an overview of the problem.

  1984cited by this paper

• Green synthesized silver nanoparticles (AgNPs) using aqueous extract of Calotropis procera and its antimicrobial activity on clinical bacteria isolates

  2024cites this paper
• Gastric epithelial response to milk fat using the semi-dynamic INFOGEST digestion model coupled with NCI-N87 cells.

  2023cites this paper
• P-glycoprotein-mediated transport in a mucus-supplemented Caco-2 cell model in the presence of different surfactants.

  2022cites this paper
• Bioaccessibility and bioavailability of phytochemicals: Influencing factors, improvements, and evaluations

  2022cites this paper
• Preparation of Janus‐type superparamagnetic iron oxide nanoparticles modified with functionalized PCL / PHEMA via photopolymerization for dual drug delivery

  2021cites this paper
• Delivery of β-carotene to the in vitro intestinal barrier using nanoemulsions with lecithin or sodium caseinate as emulsifiers

  2021cites this paper
• Interaction with biliary and pancreatic fluids drives supersaturation and drug absorption from lipid-based formulations of low (saquinavir) and high (fenofibrate) permeability poorly soluble drugs.

  2021cites this paper
• Advances in lipid carriers for drug delivery to the gastrointestinal tract

  2021cites this paper
• Lipid-based nanostructures as a strategy to enhance curcumin bioaccessibility: Behavior under digestion and cytotoxicity assessment.

  2021cites this paper
• Formation of Self-Assembled Mesophases During Lipid Digestion

  2021cites this paper
• Structured edible lipid-based particle systems for oral drug-delivery.

  2021cites this paper
• Formulation strategies to improve the efficacy of intestinal permeation enhancers.

  2021cites this paper
• Comparison of cellular monolayers and an artificial membrane as absorptive membranes in the in vitro lipolysis-permeation assay.

  2021cites this paper
• Nanostructured Lipid-Based Delivery Systems as a Strategy to Increase Functionality of Bioactive Compounds

  2020cites this paper
• Design, Development, and Characterization of Imiquimod-Loaded Chitosan Films for Topical Delivery

  2019cites this paper
• Comparison of paclitaxel solid dispersion and polymeric micelles for improved oral bioavailability and in vitro anti-cancer effects.

  2019cites this paper
• Application of Permeation Enhancers in Oral Delivery of Macromolecules: An Update

  2019cites this paper
• Nanostructured clay particles supplement orlistat action in inhibiting lipid digestion: An in vitro evaluation for the treatment of obesity.

  2019cites this paper
• In vitro digestion models to evaluate lipid based drug delivery systems; present status and current trends.

  2019cites this paper
• Magnetic Nanoparticles and Their Biomedical Applications

  2019cites this paper
• Integration of phospholipid-drug complex into self-nanoemulsifying drug delivery system to facilitate oral delivery of paclitaxel

  2018cites this paper
• Origami Biosystems: 3D Assembly Methods for Biomedical Applications

  2018cites this paper
• Labrasol® and Salts of Medium-Chain Fatty Acids Can Be Combined in Low Concentrations to Increase the Permeability of a Macromolecule Marker Across Isolated Rat Intestinal Mucosae.

  2018cites this paper
• Novel drug delivery systems, devices, and fabrication methods

  2018cites this paper
• NOVEL NANOCARRIERS FOR ETHNOPHARMACOLOGICAL FORMULATIONS

  2018cites this paper
• Caco-2 Cell Conditions Enabling Studies of Drug Absorption from Digestible Lipid-Based Formulations

  2018cites this paper